Laboratory tests and imaging studies in patients with cutaneous malignant melanoma

Journal of the American Academy of Dermatology

Volumn 39, Issue 3, 1998, Pages 451-463

  Huang, C L ^a   Provost, N ^a   Marghoob, A A ^a   Kopf, A W ^a   Levin, L ^a   Bart, R S ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGRESSION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SKIN CANCER; THORAX RADIOGRAPHY;

EID: 0031714008     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70324-X     Document Type: Article

References (120)

1. LAG Ries BA Miller BF Hankey CL Kosary A Harras BK Edwards SEER Cancer Statistics Review, 1973-1991: Tables and graphs, National Cancer Institute. 1994 NIH Pub No 94-2789 Bethesda (MD)
2. SH Landis T Murray S Bolden PA. Wingo Cancer statistics, 1998 CA Cancer J Clin 48 1998 6 29
3. TG Salopek AA Marghoob JM Slade B Rao DS Rigel AW Kopf An estimate of the incidence of malignant melanoma in the United States: based on a survey of members of the American Academy of Dermatology Dermatol Surg 21 1995 301 305
4. N Provost AA Marghoob AW Kopf M DeDavid Q Wasti RS. Bart Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians J Am Acad Dermatol 36 1997 711 720
5. 4th ed OH Beahrs DE Henson RVP Hutter BJ Kennedy Manual for staging of cancer. 1992 : JB Lippincott Philadelphia 143 147
6. AC Buzaid AB Sandler S Mani AM Curtis W-J Poo JL Bolognia Role of computed tomography in the staging of primary melanoma J Clin Oncol 11 1993 638 643
7. CM Balch AN. Houghton Diagnosis of metastatic melanoma at distant sites 2nd ed CM Balch AN Houghton GW Milton AJ Sober S-j Soong Cutaneous melanoma. 1992 : JB Lippincott Philadelphia 439 467
8. JW Kelly MS Blois RW. Sagebiel Frequency and duration of patient follow-up after treatment of a primary malignant melanoma J Am Acad Dermatol 13 1985 756 760
9. JS Markowitz LA Cosimi RW Carey S Kang C Padyk AJ Sober Prognosis after initial recurrence of cutaneous melanoma Arch Surg 126 1991 703 708
10. CA Baughan VL Hall BJ Leppard PJ. Perkins Follow-up in stage I cutaneous malignant melanoma: an audit Clin Oncol 5 1993 174 180
11. DS Rigel RJ Friedman AW Kopf R Weltman P Prioleau B Safai Importance of complete cutaneous examination for detection of malignant melanoma J Am Acad Dermatol 14 1986 857 860
12. AA Marghoob J Slade AW Kopf TG Salopek DS Rigel RS. Bart Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study Br J Dermatol 135 1996 704 711
13. AA Marghoob J Slade TG Salopek AW Kopf RS Bart DS. Rigel Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma Cancer 75 1995 707 714
14. TA Huffman WK. Sterin Ten-year survival with multiple metastatic malignant melanoma: primary site unknown Arch Surg 106 1973 234 237
15. MA Hena LJ Emrich RN Nambisan Effect of surgical treatment of stage IV melanoma Am J Surg 153 1987 270 276
16. IL Wornom JW Smith S-j Soong R McElvein MM Urist CM. Balch Surgery as palliative treatment for distant metastases of melanoma Ann Surg 204 1986 181 186
17. L Tafra PS Dale LA Wanek KP Ramming DL. Morton Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax J Thorac Cardiovasc Surg 110 1995 119 129
18. A Routh T Khansur BT Hickman D. Bass Management of brain metastases: past, present, and future South Med J 87 1994 1218 1226
19. A. Dalgleish The case for therapeutic vaccines: review Melanoma Res 6 1996 5 10
20. GS. Rogers Boron neutron capture therapy: a promising new treatment for metastatic melanoma Melanoma Lett 13 1995 1 4
21. T Petit C Borel O Rixe MF Avril A Monnier B Giroux Complete remission seven years after treatment for metastatic malignant melanoma Cancer 77 1996 900 902
22. E Stoelben J Sturm J Schmoll U Keilholz HD. Saeger Resektion von solitaren Lebermetastasen des malignen Melanoms Chirurg 66 1995 40 44
23. TK Overett MH. Shiu Surgical treatment of distant metastases: indications and results Cancer 56 1985 1222 1230
24. N Ricaniadis MM Konstadoulakis D Walsh CO. Karakousis Gastrointestinal metastases from malignant melanoma Surg Oncol 4 1995 105 111
25. AC Buzaid L Tinoco MI Ross SS Legha RS. Benjamin Role of computed tomography in the staging of patients with local-regional metastases of melanoma J Clin Oncol 13 1995 2104 2108
26. J Patel M Didolkar J Pickren R. Moore Metastatic pattern of malignant melanoma: a study of 216 autopsy cases Am J Surg 135 1978 807 810
27. N Cascinelli F Preda M Vaglini S Orefice R Bufalino A Morabito Metastatic spread of stage I melanoma of the skin Tumori 69 1983 449 454
28. A Barth LA Wanek DL. Morton Prognostic factors in 1521 melanoma patients with distant metastases J Am Coll Surg 181 1995 193 201
29. C Garbe P Buttner J Bertz G Burg B d’Hoedt H Drepper Primary cutaneous melanoma: identification of prognostic groups and estimation of individual prognosis for 5093 patients Cancer 75 1995 2484 2491
30. NIH consensus conference. Diagnosis and treatment of early melanoma JAMA 268 1992 1314 1319
31. Conference de Consensus Suivi des patients operes d’un melanoma de stade I Ann Dermatol Venereol 122 1995 250 258
32. P Rumke JJE. van Everdingen Consensus on the management of melanoma of the skin in the Netherlands Eur J Cancer 28 1992 600 604
33. CE Orfanos EG Jung G Rassner HH Wolff C. Garbe Stellungnahme und Empfehlungen der Kommission malignes Melanom der Deutschen dermatologishen Gesellschaft zur Diagnostik, Behandlung und Nachsorge des malignen Melanoms der Haut Hautarzt 45 1994 285 291
34. Schweizerische Gesellschaft fur Dermatologie und Venereologie: das primare maligne Melanom der Haut Bulle Med Suisse. 74 1993 1021 1024
35. M Weiss CL Loprinzi ET Creagan RJ Dalton P Novotny JR O’Fallon Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas JAMA 274 1995 1703 1705
36. A Jillella S Mani B Nair WJ Poo J Bolognia S Ariyan A. Buzaid The role for close follow-up of melanoma patients with AJCC Stages I-III: a preliminary analysis [abstract] Proc Am Soc Clin Oncol 14 1995 413
37. A Ardizzoni A Grimaldi L Repetto M Bruzzone MR Sertoli R. Rosso Stage I-II melanoma: the value of metastatic work-up Oncology 44 1987 87 89
38. N Iscoe P Kersey J Gapski D Osoba L From G DeBoer Predictive value of staging: investigations in patients with clinical stage I malignant melanoma Plast Reconstr Surg 80 1987 233 237
39. PA Kersey NA Iscoe JAP Gapski D Osoba L From G DeBoer The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma Br J Surg 72 1985 614 617
40. GM Zartman MR Thomas WA. Robinson Metastatic disease in patients with newly diagnosed malignant melanoma J Surg Oncol 35 1987 163 164
41. JE Meyer L. Stolbach Pretreatment radiographic evaluation of patients with malignant melanoma Cancer 42 1978 125 126
42. JA Roth FR Eilber LR Bennett DL. Morton Radionucleotide photoscanning: usefulness in preoperative evaluation of melanoma patients Arch Surg 110 1975 1211 1212
43. JH Thomas D Panoussopoulous GE Liesmann WR Jewel DF. Preston Scintiscans in the evaluation of patients with malignant melanomas Surg Gynecol Obstet 149 1979 574 576
44. RA Evans KI Bland MJ McMurtrey AJ. Ballantyne Radionuclide scans not indicated for clinical stage I melanoma Surg Gynecol Obstet 150 1980 532 534
45. FC Au WP Maier LS Malmud LI Godman WH. Clark Preoperative nuclear scans in patients with melanoma Cancer 53 1984 2095 2097
46. PE Jonsson L Hafstrom A Hugander E. Cederquist Value of liver scintigraphy in pretreatment staging and in follow-up of patients with malignant melanoma J Surg Oncol 29 1985 22 25
47. HB Muss F Richards PL Barnes W Willard RJ. Cowan Radionuclide scanning in patients with advanced malignant melanoma Clin Nucl Med 4 1979 516 519
48. D Devereux G Johnston L Blei G Head R Makuch M. Burt The role of bone scans in assessing malignant melanoma in patients with stage III disease Surg Gynecol Obstet 151 1980 45 49
49. N Basseres JJ Grob MA Richard X Thirion H Zarour C Noe Cost-effectiveness of surveillance of Stage I melanoma: a retrospective appraisal based on a 10-year experience in a dermatology department in France Dermatology 191 1995 199 203
50. T Khansur J Sanders SK. Das Evaluation of staging workup in malignant melanoma Arch Surg 124 1989 847 849
51. G Goerz R Schulte-Beerbuhl K Roder WD Schoppe C Munchhoff RM. Jungblut Malignant melanoma: Which examinations are useful in staging and follow-up? Dtsch Med Wochenschr 111 1986 1230 1233
52. A Tregnaghi A De Candia M Calderone L Cellini CR Rossi E Talenti Ultrasonographic evaluation of superficial lymph node metastases in melanoma Eur J Radiol 24 1996 216 221
53. BW Kuvshinoff C Kurtz DG. Coit Computed tomography in evaluation of patients with stage III melanoma Ann Surg Oncol 4 1997 252 258
54. TM Johnson DJ Fader AE Chang A Yahanda JW Smith KR Hamlet Computed tomography in staging of patients with melanoma metastatic to the regional nodes Ann Surg Oncol 4 1997 396 402
55. I Reider-Growasser O Merimsky N Karminsky S Chaitchik Computed tomography features of cerebral spread of malignant melanoma Am J Clin Oncol 19 1996 49 53·
56. I Kostrubiak NO Whitley J Aisner P Goose R Russell RR DeLuca The use of computed body tomography in malignant melanoma JAMA 259 1988 2896 2898
57. C Berman D. Reintgen Radiologic imaging in malignant melanoma: a review Semin Surg Oncol 9 1993 232 238
58. N Chalmers JJK. Best The significance of pulmonary nodules detected by CT but not by chest radiography in tumour staging Clin Radiol 44 1991 410 412
59. MJ Doiron ME. Bernardino A comparison of noninvasive imaging modalities in the melanoma patient Cancer 1 1981 2581 2584
60. RC Semelka JP Shoenut SM Ascher MA Kroeker HM Greenberg CS Yaffe Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MRI imaging with fat-suppressed T2-weighted, breath-hold Tl-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences J MRI 4 1994 319 323
61. SJ Finck AE Giuliano DL. Morton LDH and melanoma Cancer 51 1983 840 843
62. R Garg TA McPherson B Lentle F. Jackson Usefulness of an elevated serum lactate dehydrogenase value as a marker for hepatic metastases in malignant melanoma Can Med Assoc J 120 1979 1114 1116
63. E Campora L Repetto P Giuntini G. Bertelli LDH in the follow-up of stage I malignant melanoma [letter] Eur J Clin Oncol 24 1988 277 278
64. JL Murray MP Lerner RE Nordquist Elevated gamma-glutamyl transpeptidase levels in malignant melanoma Cancer 49 1982 1439 1443
65. C Aubert E Rosengren H Rorsman F Rouge C Foa C. Lipcey 5-S-Cysteinyldopa in diagnosis and treatment of human malignant melanoma and ultrastructural observations Eur J Cancer 13 1977 1299 1308
66. LL Peterson WR Woodward WS Fletcher M Palmquist MA Tucker A. Ilias Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patient with dysplastic nevus syndrome and normal subjects J Am Acad Dermatol 19 1988 509 515
67. H Hara N Walsh K Yamada K. Jimbow High plasma level of eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a prognostic marker for malignant melanoma J Invest Dermatol 102 1994 501 505
68. K Yamada N Walsh H Hara K Jimbow H Chen S. Ito Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases Arch Dermatol 128 1992 491 494
69. BA Faraj VM Camp DR Murray M Kutner J Hearn D. Nixon Plasma L-dopa in the diagnosis of malignant melanoma Clin Chem 32 1986 159 161
70. EP Wraight DR Bard TS Maughan CG Knight DP. Page-Thomas The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma Br J Rad 65 1992 112 118
71. NN Trapeznikov MO Raushenbakh VD Ivanova VV. Yavorsky Clinical evaluation of a method of quantitative determination of homovanillic acid for the estimation of degree of tumor dissemination process in melanoma of the skin Cancer 36 1975 2064 2068
72. LR Morgan D Lolley B Maddox MS Samuels ET Krementz Urine homovanillic acid and tissue dopa oxidase in patients with melanoma Cancer 33 1974 1601 1606
73. G Schwartze H. Fiedler The diagnostic significance of alpha-MSH in malignant melanoma of man Hautarzt 45 1994 468 470
74. AC Buzaid AB Sandler CL Hayden J Scinto WJ Poo MB Clark Neuron-specific enolase as a tumor marker in metastatic melanoma Am J Clin Oncol 17 1994 430 431
75. AH Ryan JJ. Fennelly Serum sialic acid concentrations in malignant melanoma Eur J Cancer Clin Oncol 17 1981 843 844
76. JH Wong SH Xu KA Skinner LJ Foshag DL. Morton Prospective evaluation of the use of antigenic-specific immune complexes in predicting the development of recurrent melanoma Arch Surg 126 1991 1450 1454
77. R Kagan T Witt S Bines G Mesleh S. Economou Gallium-67 scanning for malignant melanoma Cancer 61 1988 272 274
78. S Rodot J Darcourt F Bussiere JP Lacour O Migneco A Thyss A radiolabeled iodobenzamide for malignant melanoma staging Melanoma Res 4 1994 307 312
79. L Maffioli L Mascheroni V Mongioj M Gasparini MT Baldini E Seregni Scintigraphic detection of melanoma metastases with a radiolabeled benzamide J Nucl Med 114 1994 912 914
80. L Feggi M Indelli GC Pansini A Santini N Prandini AR. Virgili Immunoscintigraphy in malignant melanoma: a five-year clinical experience Nucl Med Commun 14 1993 145 148
81. R Boni RA Huch Boni H Steinert R Dummer G Burg GK. von Schulthess Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma Dermatology 191 1995 119 123
82. F Salzillo M Mele T Lombardo N Delle Noci C Minervini A D’Addabbo Radioimmunoscintigraphy with 99mTc-225.28S-F(ab')2 in cutaneous and ocular melanomas: cases of particular clinical interest J Nucl Biol Med 37 1993 191 197
83. MJ Blend H Hyun B Patel K Sullivan D. Salk Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma J Nucl Med 37 1996 252 257
84. MJ Blend SG Ronan DJ Salk TK. Das Gupta Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients J Clin Oncol 10 1992 1330 1337
85. GS. Rogers Advances in diagnostic technique: melanoma update J Dermatol Surg Oncol 15 1989 605 607
86. T Cerny SE Owens SA Mackenzie PM Nuttall AK Gosh DB Smith Immunoscintigraphy with 99mTc labeled F(ab')2 fragments of an antimelanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma Eur J Nucl Med 13 1987 130 133
87. C Muller A Le Pape M Musset J-L Baulieu A DeLarue H Binz Scintigraphy with 99mTechnicium-J001X acylated polygalactoside in melanoma recurrence Eur J Dermatol 5 1995 600 606
88. HC Steinert RA Huch Boni A Buck R Boni T Berthold B Marincek Malignant melanoma: staging with whole-body positron emission tomography and 2-(F-18)-fluoro-2-deoxy-D-glucose Radiology 195 1995 705 709
89. R Boni RA Huch Boni H Steinert G Burg A Buck B Marincek Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose Br J Dermatol 132 1995 556 562
90. R Boni RA Huch-Boni H Steinert GK von Schulthess G. Burg Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography Arch Dermatol 132 1996 875 876
91. LS Gritters IR Francis KR Zasadny RL. Wahl Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-d-glucose in the imaging of malignant melanoma J Nucl Med 34 1993 1420 1427
92. DL Damian MJ Fulham E Thompson JF. Thompson Positron emission tomography in the detection and management of metastatic melanoma Melanoma Res 6 1996 325 329
93. C Blessing U Feine L Geiger M Carl G Rassner G. Fierlbeck Positron emission tomography and ultrasonography: a comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma Arch Dermatol 131 1995 1394 1398
94. JD Wagner D Schauwecker G Hutchins JJ Coleman III. Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma J Surg Oncol 64 1997 181 189
95. HB Guo B Stoffel-Wagner T Bierwith J Mezger D. Klingmuller Clinical significance of serum S100 in metastatic malignant melanoma Eur J Cancer 31 1995 924 928
96. G Henze R Dummer HI Joller-Jemelka R Boni G. Burg Serum S100: a marker for disease monitoring in metastatic melanoma Dermatology 194 1997 208 212
97. BJ Curry MJ Smith P. Hersey Detection and quantification of melanoma cells in the circulation of patients Melanoma Res 6 1996 45 54
98. Z Battayani JJ Grob L Xerri C Noe H Zarour G Houvaeneghel Polymerase chain reaction detection of circulating melanocytes as a prognostic in patients with melanoma Arch Dermatol 131 1995 443 447
99. X Wang R Heller N VanVoorhis CW Cruse F Glass N Fenske Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma Ann Surg 220 1994 768 774
100. FA Jung AC Buzaid MI Ross KV Woods JJ Lee M Albitar Evaluation of tyrosinase mRNA as a tumor marker in blood of melanoma patients J Clin Oncol 15 1997 2826 2831
101. R Glaser K Rass S Seiter A Hauschild E Christophers W. Tilgen Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable marker in melanoma patients: a clinical two-center study J Clin Oncol 15 1997 2818 2825
102. DSB Hoon Y Wang PS Dale AJ Conrad P Schmid D Garrison Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay J Clin Oncol 13 1995 2109 2116
103. GS Hanekom CA Johnson SH Kidson An improved and combined reverse transcription–polymerase chain reaction assay for reliable detection of metastatic melanoma cells in peripheral blood Melanoma Res 7 1997 111 116
104. D Schandendorf R Herfordt BM. Czarnetzki P-glycoprotein expression in primary and metastatic malignant melanoma Br J Dermatol 132 1995 551 555
105. N Gritzmann H Czembirek P Hajek F Karnel R Turk F. Fruwald Sonographie bei zervikalen Lymphknoten-metastasen Radiologie 27 1987 118 122
106. H Stutte S Erbe G. Rassner Lymph node sonography in the care of malignant melanoma Hautarzt 40 1989 344 349
107. BD Fornage JG. Lorigan Sonographic detection and fine-needle aspiration biopsy of nonpalpable recurrent or metastatic melanoma in subcutaneous tissues J Ultrasound Med 8 1989 421 424
108. CM Balch S-j Soong HM Shaw MM Urist WH. McCarthy An analysis of prognostic factors in 8500 patients with cutaneous melanoma 2nd ed CM Balch AN Houghton GW Milton AJ Sober S-j Soong Cutaneous melanoma. 1992 : JB Lippincott Philadelphia 165 199
109. MN Sirott DF Bajorin GYC Wong Y Tao PB Chapman MA Templeton Prognostic factors in patients with metastatic malignant melanoma: a multivariate analysis Cancer 72 1993 3091 3098
110. AN Houghton CM. Balch Treatment for advanced melanoma 2nd ed CM Balch AN Houghton GW Milton AJ Sober S-j Soong Cutaneous melanoma. 1992 : JB Lippincott Philadelphia 468 497
111. DK Heaston CE Putman BA Rodan E Nicholson CE Ravin M Korobkin Solitary pulmonary metastases in high-risk melanoma patients: a prospective comparison of conventional and computed tomography Am J Roentgenol 141 1983 169 174
112. K Horgan LE. Hughes Staging of melanoma Clin Radiol 48 1993 297 300
113. H Stutte PH Muller B d’Hoedt W Stroebel Ultrasonographic diagnosis of melanoma metastases in liver, gallbladder, and spleen J Ultrasound Med 8 1989 541 547
114. IF al-Sheneber SH Meterissian A Loutfi AK Watters HR. Shaibata Small-bowel resection for metastatic melanoma Can J Surg 39 1996 199 203
115. MS Brady DG. Coit Sentinel lymph node evaluation in melanoma Arch Dermatol 133 1997 1014 1020
116. DL Morton DR Wen JH Wong JS Economous LA Cagle FK Storm Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392 399
117. D Reintgen CM Balch J Kirkwood M. Ross Recent advances in the care of the patient with malignant melanoma Ann Surg 225 1997 1 14
118. D Reintgen J. Kirkwood The adjuvant treatment of malignant melanoma J Fla Med Assoc 84 1997 147 152
119. JF Thompson WH McCarthy CMJ Bosch CJ O’Brien MJ Quinn S Paramaesvaran Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes Melanoma Res 5 1995 255 260
120. A. Breslow Thickness, cross sectional areas and depth of invasion in the prognosis of cutaneous melanoma Ann Surg 172 1970 902 908